1. Home
  2. SONY vs BMY Comparison

SONY vs BMY Comparison

Compare SONY & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sony Group Corporation

SONY

Sony Group Corporation

HOLD

Current Price

$21.89

Market Cap

127.6B

ML Signal

HOLD

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

HOLD

Current Price

$57.26

Market Cap

115.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SONY
BMY
Founded
1946
1887
Country
Japan
United States
Employees
112300
32500
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.6B
115.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SONY
BMY
Price
$21.89
$57.26
Analyst Decision
Hold
Buy
Analyst Count
1
15
Target Price
$22.00
$61.73
AVG Volume (30 Days)
7.4M
8.9M
Earning Date
05-13-2026
04-30-2026
Dividend Yield
5.33%
4.38%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.08
N/A
P/E Ratio
N/A
$17.26
Revenue Growth
N/A
N/A
52 Week Low
$19.63
$42.52
52 Week High
$30.34
$62.89

Technical Indicators

Market Signals
Indicator
SONY
BMY
Relative Strength Index (RSI) 51.16 50.47
Support Level $21.35 $56.36
Resistance Level $23.30 $60.50
Average True Range (ATR) 0.37 1.40
MACD -0.05 -0.08
Stochastic Oscillator 22.51 50.58

Price Performance

Historical Comparison
SONY
BMY

About SONY Sony Group Corporation

Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is the global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with five major business segments.

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: